Canadian and U.S. BSE Risk Steven Anderson, Ph.D, MPP Office of Biostatistics & Epidemiology Center for Biologics Evaluation & Research U.S. Food & Drug.

Slides:



Advertisements
Similar presentations
Advanced Animal Science Consumption Patterns Relative to Diet (c)(5)(B) Created By: Rodree Carlile.
Advertisements

Teaching Workshop Bovine Spongiform Encephalopathy (BSE) Specified Risk Materials (SRMs)
Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.
1 BSE and the Alberta Beef Industry Presentation to Canada/US Transportation Border Working Group Calgary, Alberta October 20, 2004 Nithi Govindasamy,
1 Donor Deferral / Ineligibility for Time Spent in Saudi Arabia to Reduce Risk of vCJD Transmitted by Blood and Blood Products and by Human Cells, Tissues.
Consumer Issues Food Animal Concerns Trust Dr. Richard Wood Executive Director Steven Roach, Food Safety Program Manager FDA Animal Feed Safety System.
Ron Plain D. Howard Doane Professor University of Missouri-Columbia Chicken & Competing Meats.
Proposed SRM Disposal Permitting Process Natalie Bragg, D.V.M., M.Sc., Animal Health and Production Canadian Food Inspection Agency.
Food Safety and Inspection Service Overview of New Regulations and Policies to Further Enhance Safeguards Against Bovine Spongiform Encephalopathy (BSE)
Taking Dead Aim At The US Cattle Business. AN OVER-VIEW OF THE USA CATTLE MARKET & FUTURE THREATS Global Animal Products, Inc. (US Office) Ken Ridenour,
Analysis to Inform Decisions: Evaluating BSE Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of Public Health.
Ron Plain, Ph.D. Professor of Agricultural Economics University of Missouri-Columbia Hog Market Forecast 2004 Iowa.
Mad Cow Disease 袁聖甯 黃竹瑄 鄧雯心. What is Mad Cow Disease ? A kind of transmissible spongiform encephalopathies (TSE) Occurs in many mammals, including human.
Outlook for the U.S. Livestock and Poultry Sectors in 2011 Presented By Shayle D. Shagam World Agricultural Outlook Board, USDA USDA Outlook Forum Washington,
Value of Animals to Humanity Chapter 2. FOOD USES Value of Animals to Humanity.
The Largest Segment of Georgia Agriculture 2006 Farm Cash Receipts -- Percent Total by Commodity Prepared by: Georgia Poultry Federation Source: Georgia.
BSE outbreaks in the United States and Canada and the Impact on Trade Hyun J. Jin Won W. Koo Center for Agricultural Policy and Trade Studies North Dakota.
Are humans susceptible?
Joining the links of a Greener meat chain Stephen Woodgate, Chief Executive.
Overview of North American Cattle Trade Issues Christie Guinn Master of Agriculture Seminar Dr. Rhonda Skaggs, Advisor.
Bovine Spongiform Encephalopathy Luke VanNatter Carrie Pell Amy Richwine Scott Inskeep Kristina Anderson.
Mad Cow Disease. Effects of Mad Cow disease Mad cow disease, or bovine spongiform encephalopathy (BSE), is a fatal brain disorder that occurs in cattle.
7/15/ From information, knowledge Hog and Pork Issues and Outlook Steve R. Meyer Paragon Economics, Inc. Midwest, Great Plains & Western Outlook.
Bovine Spongiform Encepalopathy, BSE Should FAO have maintained its silence?
Harvard Center for Risk Analysis Evaluation of the Potential for BSE in the United States Joshua T. Cohen Keith Duggar George M. Gray Silvia Kreindel Harvard.
OVERVIEW of WORLD & U.S. BEEF CATTLE INDUSTRIES By David R. Hawkins Michigan State University.
FSIS Enforcement of Animal Drug Tolerances in Imported Meat and Poultry Products Food Safety and Inspection Service Veterinary Medicine Advisory Committee.
BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) or “Mad Cow Disease”: Cause and effect on the beef market. Name: Odette K Busambwa.
 Caused by parasite › Transmitted by mosquito › Once injected into the human, the parasite grows and multiples first in the liver and then the red blood.
1 Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE) Joshua T. Cohen, Ph.D. The Center for the Evaluation of Value and Risk Institute for.
Food Safety: A Challenge for the Food Science and Technology Community Dr Gerald Moy GEMS/Food Manager Programme of Food Safety World Health Organization.
Teaching Workshop Bovine Spongiform Encephalopathy (BSE)
BSE in the US APHIS Investigation and Response FDA TSE Advisory Committee February 12, 2004 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS,
Food Chain Disruptions & Trade 2005 Agricultural Outlook Forum Washington, D.C. February 25, 2005 Parr Rosson Professor & Director Center for North American.
Biowaste Disposal and Utilization John Scanga Center for Red Meat Safety Department of Animal Sciences Colorado State University John Scanga Center for.
Bovine-derived Products Used in the Manufacture and Formulation of Vaccines and Allergenic Products: Minimizing TSE Risks William M. Egan, Ph.D. Acting.
Hot, Crowded and Legal A Look at Industrial Agriculture in Brazil and the United States David Cassuto Professor of Law, Pace Law School Director, Brazil-American.
Risk Assessments: Models for Estimating the Risk of Transmitting TSE by Human Tissue Intended for Transplantation Rolf E. Taffs, Ph.D. Center for Biologics.
BSE/TSE measures – state of play and future work Plenary of the Advisory Group on the Food Chain, Animal and Plant Health 19 December 2008.
January 2002 WHO/CSR/APH Efforts and needs for global control of BSE and vCJD Maura N. Ricketts MD MHSc FRCPC WHO/CDS/CSR/EPH.
BSE: World Situation and USDA Response FDA TSE Advisory Committee Silver Spring, MD October 14, 2004 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA,
FDA TSE Advisory Committee Meeting October 25, 2001 Topic 2 Amino Acid Production and the Associated Theoretical Risk of BSE Transmission from their Use.
Teaching Workshop Bovine Spongiform Encephalopathy (BSE) Advanced Meat Recovery (AMR)
Trade & Economic Impacts of Animal Disease Outbreaks Parr Rosson Professor & Director Center for North American Studies Texas A&M University.
Risk-Based Sourcing for Bovine Materials in FDA-regulated Medical Products: Introduction and General Considerations FDA TSE Advisory Committee Meeting.
TSE Advisory Committee October 25, 2001 Center for Food Safety and Applied Nutrition Food and Drug Administration Washington, DC Topic 3.
Mad Cow Disease Making sense of the headlines by Trevor Murdock.
RISK COMMUNICATION APPROACH TSEAC 15 December 2006 Mark Weinstein, Ph.D. FDA, Center for Biologics Evaluation and Research.
Draft Risk Assessment for UK manufactured Factor XI and Potential vCJD Exposure Steven Anderson, PhD, MPP Office of Biostatistics & Epidemiology Center.
Hong Yang, Ph.D. Office of Biostatistics and Epidemiology FDA-Center for Biologics Evaluation & Research Transmissible Spongiform Encephalopathies Advisory.
BSE: World update FDA TSE Advisory Committee Gaithersburg, MD September 18, 2006 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS, Veterinary.
Microbes and Diseases Chapter 02. CREUTZFELDT-JAKOB DISEASE Prion.
Preliminary Risk Assessment Model for U.S. Plasma Derivatives and vCJD Steven Anderson, PhD, MPP Office of Biostatistics & Epidemiology Center for Biologics.
VCJD World situation and Updates RG Will National CJD Research and Surveillance Unit Edinburgh, UK TSEAC meeting 1 st August 2011.
MAD COW DISEASE Anna Hoffmann. What is it?  Mad cow disease, or bovine spongiform encephalopathy (BSE), is a transmissible, slowly progressive fatal.
Topic 1: FDA Draft Guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by Blood and Blood Products” Dorothy.
Deferral of Blood and Plasma Donors for History of Transfusion in BSE Countries of Europe Alan E. Williams, Ph.D. Director, Division of Blood Applications.
David M. Asher, MD Division of Emerging & Transfusion-Transmitted Diseases Office of Blood Research & Review Center for Biologics Evaluation & Research.
United States Department of Agriculture Food Safety and Inspection Service Uday Dessai, MS, Ph.D., M.P.H. Director, Microbiology Division Office of Public.
1 A Simulation Model to Quantify the Spread of BSE in the United States Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of.
Draft Quantitative Risk Assessment of vCJD Risk Potentially Associated with the Use of Human Plasma-Derived Factor VIII Manufactured Under United States.
August 2008 Bovine Spongiform Encephalopathy (BSE) Billy Moss Area Livestock Teacher North Region Agricultural Education February 2004.
Bovine Spongiform Encephalopathy Variant Creutzfeldt-Jakob disease
Livestock and meat industry
Frequently Asked Questions About BSE
FDA TSE Advisory Committee Meeting
Agricultural Marketing
The Government’s Role in Stabilizing Beef Supply when BSE Strikes
Equine Euthanasia and Disposal Challenges
The Integration of the North American Meat Supply Chain Presentation for the FAMPS Track Organized Symposium: Impacts of North American Economic Integration.
Presentation transcript:

Canadian and U.S. BSE Risk Steven Anderson, Ph.D, MPP Office of Biostatistics & Epidemiology Center for Biologics Evaluation & Research U.S. Food & Drug Administration TSE Advisory Committee February 12, 2004

Policy questions for BSE in North America What is the BSE risk for the U.S. and Canada? Part I - Estimating BSE risk: Potential exposure pathways in U.S. and Canada What is the risk for the general U.S. population? What are the implications for the blood supply? Part II – Estimating BSE exposure and risks in the U.S.

North American beef production statistics U.S.A.Canada Total Cattle96.1 million13.3 million Slaughtered35.7 million3.6 million Commercial carcass weight (est) 27 billion lbs~3.8 billion lbs Total beef (bone-in)8.75 million metric tons 908,000 metric tons % Beef exported~ 9.8 %> 60%

Part I – Estimating BSE risk: Potential exposure pathways in U.S. and Canada Imports from BSE countries of: A. Live animals B. Mammalian-derived feed ingredients Meat and bone meal, meals, etc. C. U.S. and Canada – bilateral imports / exports Has implications for movement of potentially infected cattle and contaminated products Focus on imports from: U.K. - since 1980 BSE countries - since 1986

Potential Exposure Pathways – Live Animals A. Cattle Imports from United Kingdom U.S.A.Canada Total Animals imported Disposition known Imports from UK farms with known BSE cases 010 Disposition unknown BSE positives (1993) cow from U.K. 1

Potential Exposure Pathways – Live Animals A. Cattle Imports from BSE countries U.S.A.Canada Total Animals imported , Imports Ireland / Europe before 1986 (low risk) Total Animals imported from U.K. since Other BSE countries since

Potential Exposure Pathways – Feed B. Feed ingredients from BSE countries U.S. feed meal imports from UK since 1980 – total 81 tons 12 tons in tons in tons in tons in 1989 ( Disputed by U.S. authorities) 37 tons in 1997 U.S.A. imported ~10,500 metric tons of inedible meat byproducts from from BSE countries Canada reported no MBM imports from UK since Canada imported ~8,523 metric tons of mammalian flours, meals, meat pellets from from Denmark, Germany, Japan & France.

C.Cattle and beef trade in North America Considerable movement of animals, feed ingredients, and beef products Trade and production practices similar for each country Import/export could introduce or spread infected animals or contaminated products

C. Cattle trade in North America U.S. Cattle imports and exports 1992 to 2002

C. Beef trade in North America U.S. Beef imports and exports 1992 to 2002

Conclusions Part I: Estimating BSE risk U.S. and Canada Difficult to estimate absolute risk for U.S. and Canada Most potential for introduction of BSE agent would have occurred prior to 1990 Potential amount of BSE agent introduced unknown Numerous chance events would be involved over last 10 to 15 years Rendering Fed to other cattle, dead on farm, etc. Imports of live animals and feed materials from BSE countries occurred since 1980 but was small Qualitative estimate of risk predicted to be low but difficult to estimate with certainty

Part II – Estimating BSE exposure and risks for the US population Many potential routes for human exposure to beef and bovine products Primary source of potential BSE exposure Food High risk tissues – brain, spinal cord, eyes, dorsal root ganglia, small intestine Other sources Dietary supplements Medical products – devices, biologics, drugs

II. BSE exposure pathways for US population via beef A. Consumption of large amounts high risk tissue (very low probability event) Bovine brain or spinal cord B. Consumption of small amounts high risk tissues in processed foods Advanced meat recovery beef product Ground beef products, beef sausages, hot dogs, processed meat sauces, etc.

II. BSE exposure pathways for US population via beef U.S. risk Probability of exposure to infected cow in positive identified – 35 million slaughtered 1 in 35 million ( 3.5 x ) Worst case – Based on statistical analysis USDA surveillance (~20,000 tests) ~1 in 1 million (1 x )

A. Consumption of large amounts high risk tissue: bovine brain Probability of exposure: brain rarely consumed by Americans (100,000 – 180,000 servings) Many servings from low risk cattle – calf brains, etc. Probability infected brain in x to Quantity of exposure: assume brain late stage BSE-infected cow 5,000 to 6,500 cattle oral ID 50 Conclusions: There is risk of exposure via this route Risk to the U.S. general population is low

B. Consumption of small amounts high risk tissue: advanced meat recovery Advanced Meat Recovery (AMR): Removes remaining meat from carcass, vertebral column and bone by machinery Spinal cord usually removed before process Dorsal root ganglia on vertebral column > 70% of carcasses processed with AMR Process would mix and dilute residual BSE agent present

B. Consumption of small amounts high risk tissue: advanced meat recovery Machines can process 4,500 to 7,000 lbs bones per hour Represents material from 20 to >35 animals 5 – 10 lbs meat recovered per carcass Estimated as much as 250 million lbs AMR meat produced annually

B. Consumption of small amounts high risk tissue: advanced meat recovery Probability of exposure: advanced meat recovery (AMR) product consumed frequently Dilution of BSE infectivity throughout a batch of AMR product Probability infected cow in x to annually Amount BSE infectivity present – estimated to be low because of dilution via AMR Estimate ~ < 2 x (<4 x to 2 x ) cattle oral ID 50 per average serving Greater than a hundred of servings from each batch of AMR product

B. Consumption of small amounts high risk tissue: advanced meat recovery Assuming BSE infected animal(s) enter AMR and residual infectivity present in vertebral column: Probability exposure via AMR is low 1 x10 -7 to 2 x10 -5 per serving beef AMR product per year Probability of infection even lower Assuming a species barrier of 1,000 Reduction by oral route of >90% Assume ~40% population sensitive - methionine homozygous at codon 129 of PrP Probability of infection would be estimated to be less than < 3 x10 -9 (2 x to 3 x10 -9 ) annually in the U.S.

B. Consumption of small amounts high risk tissue: advanced meat recovery Conclusions Our preliminary estimates suggest that there is a low risk of human exposure to BSE agent via beef AMR product Probability of human infection even lower There is uncertainty in the estimates and some assumptions were made to estimate the risk Risk to general population and blood supply is low

Recent BSE risk-reduction measures for food supply & feed Should dramatically reduce small BSE risk for U.S.A. Recent USDA measures Dec 30, 2003 prohibit: Use of “downers” for human food High risk tissue in AMR Use of animals >30 months in AMR January 2003 FDA feed ban prohibits: Ruminant blood protein in feed Plate waste, poultry litter Requires dedicated feed processing lines for non- prohibited and prohibited feeds

Acknowledgements Dr. Sonja Sandberg (OBE) Rene Suarez-Soto (OBE) Dr. David Asher (OBRR) Dr. Rolf Taffs (OBRR) Dr. Pedro Piccardo (OBRR) Others at CBER

Factors considered in estimation Total cattle slaughtered annually 70% - 80% processed via AMMR # animals/batch 5-9lbs AMR per Animal Percentage lost to imports, waste, non-use Conversion lbs to servings Total est AMR meat servings /yr Servings AMR meat contaminated/Total AMR servings per yr And / or Dilution of ID50s from 1 cow in a batch of AMR